Article thumbnail

NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle

By Kristina Heyne, Vivienne Willnecker, Julia Schneider, Marcel Conrad, Nina Raulf, Roland Schüle and Klaus Roemer

Abstract

p63 is a sequence-specific transcription factor that regulates epithelial stem cell maintenance and epithelial differentiation. In addition, the TAp63 isoform with an N-terminal transactivation domain functions as an inducer of apoptosis during the development of sympathetic neurons. Previous work has indicated that the co-activator and histone acetyltransferase (HAT), p300, can bind to TAp63 and stimulate TAp63-dependent transcription of the p21Cip1 gene. Novel INHAT Repressor (NIR) is an inhibitor of HAT. Here, we report that the central portion of NIR binds to the transactivation domain and the C-terminal oligomerization domain of TAp63. NIR is highly expressed in G2/M phase of the cell cycle and only weakly expressed in G1/S. Furthermore, except during mitosis, NIR is predominantly localized in the nucleolus; only a small portion co-localizes with TAp63 in the nucleoplasm and at the p21 gene promoter. Consistent with NIR acting as a repressor, the induced translocation of NIR from the nucleolus into the nucleoplasm resulted in the inhibition of TAp63-dependent transactivation of p21. Conversely, knockdown of NIR by RNAi stimulated p21 transcription in the presence of TAp63. Thus, NIR is a cell-cycle-controlled, novel negative regulator of TAp63. The low levels of nucleoplasmic NIR might act as a buffer toward potentially toxic TAp63

Topics: Gene Regulation, Chromatin and Epigenetics
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2879503
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). A dominant-negative form of p63 is required for epidermal proliferation in zebrafish.
  2. (2004). A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.
  3. (2008). A skin microRNA promotes differentiation by repressing ‘stemness’.
  4. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
  5. (1997). Binding and modulation of p53 by p300/CBP coactivators.
  6. (2000). binding protein and mediates transcriptional activation and apoptosis.
  7. (2004). CBP and p300: HATs for different occasions.
  8. (2005). Cellular stress and nucleolar function.
  9. (2007). Conflicting roles for p63 in skin development and carcinogenesis.
  10. (2003). DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
  11. (2002). Differential expression of p63 isoforms in normal tissues and neoplastic cells.
  12. (2005). Differential recognition of response elements determines target gene specificity for p53 and p63.
  13. (2004). Direct binding of INHAT to H3 tails disrupted by modifications.
  14. (1999). Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
  15. (2002). DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
  16. (2007). Fog of war: the emerging p53 family.
  17. (2009). Histone deacetylases: salesmen and customers in the post-translational modification market.
  18. (2007). Hitting the numbers: the emerging network of p63 targets.
  19. (1988). Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals.
  20. (2005). Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
  21. (2005). NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.
  22. (2001). p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
  23. (2001). p300 does not require its acetylase activity to stimulate p73 function.
  24. (2005). p300 regulates p63 transcriptional activity.
  25. (2006). p53/ p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
  26. (2007). p63 in skin appendage development.
  27. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis.
  28. (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.
  29. (2006). p63 regulates an adhesion programme and cell survival in epithelial cells.
  30. (2006). p63 regulates proliferation and differentiation of developmentally mature keratinocytes.
  31. (2007). p63 transcriptional regulation of epithelial integrity and cancer.
  32. (2007). p63-associated disorders.
  33. (1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
  34. (1997). Recruitment of p300/CBP in p53-dependent signal pathways.
  35. (2001). Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.
  36. (2002). Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex.
  37. (2006). Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
  38. (1992). Relocation of nucleolar proteins around chromosomes at mitosis. A study by confocal laser scanning microscopy.
  39. (2005). Role of nucleophosmin in embryonic development and tumorigenesis.
  40. (2005). Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.
  41. (2008). Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.
  42. (2007). The roles of p63 in cancer.
  43. (2005). The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.
  44. (2007). The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis.
  45. (2007). To die or not to die: neurons and p63.
  46. (2008). Transcriptional control of human p53-regulated genes.
  47. (2007). Transcriptional programs regulated by p63 in normal epithelium and tumors.